Indian pharma can grow to $65 billion industry, says Minister

16 October 2020
taj-mahal-big

India's Chemicals and Fertilizers Minister D V Sadananda Gowda has invited Latin American and Caribbean countries to invest in the Indian pharma sector, stating that it could grow to become a $65 billion industry by 2024. With the government recently launching schemes for the development of drug parks across the country, the Minister said India could well replace China as the world's factory, reports The Pharma Letter’s India correspondent.

Addressing a video conference, the Minister highlighted that India is one of the largest manufacturers and exporters of generic medicines across the world, and that it is the only country with the largest number of US Food and Drug Administration-compliant pharma plants (more than 262 including APIs) outside of the USA.

Mr Gowda said India exports over $20 billion worth of pharma products to various countries, including "high standards complying countries" like the US and Europe.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics